ECTRIMS 2022 | Understanding inflammation and progression in multiple sclerosis

Eva Kubala Havrdová, MD, PhD, General University Hospital, Charles University, Prague, Czechia, describes how inflammation and progression are both present even before disease onset and throughout the course of the disease and not as sequential events. Therefore, it is important to understand that when treatment is started after the first attack, inflammation and progression are already present, highlighting the need for effective early therapies. This interview took place at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Congress 2022 in Amsterdam, The Netherlands.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.